FDA inspection
AltaThera Pharmaceuticals LLC: FDA inspection ending Jun 17, 2022
FDA inspection 1172132 · Voluntary Action Indicated (VAI) · Chicago, IL
Key facts
| Inspection ID | 1172132 |
|---|---|
| Firm | AltaThera Pharmaceuticals LLC |
| FEI number | 3013989010 |
| Address | 311 S Wacker Dr Ste 6030 |
| City | Chicago |
| State | IL |
| ZIP | 60606 |
| Country | United States |
| Fiscal year | 2022 |
| Inspection end date | Jun 17, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data